Company Profile
Updated: 28-DEC-09Biodel Inc.
Public Company, Headquarters Location
100 Saw Mill Rd., Danbury, CT 06810-5106, United States
(203)796-5000, (203)796-5001 fax, http://www.biodel.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Pharmaceuticals for treating endocrine disorders.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Biodel Reports Fourth Quarter and Fiscal Year 2009 Financial Results.(Financial report)
Business Wire; 12/10/2009; 2036 words; ...at 8:30 AM DANBURY, Conn. -- Biodel Inc. (Nasdaq: BIOD) today reported...Fiscal Year 2009 Financial Results Biodel reported a net loss for the quarter...to employees and non-employees. Biodel did not recognize any revenue during...
Biodel to Report Fourth Quarter and Fiscal Year 2009 Financial Results on December 10, 2009.(Financial report)
Business Wire; 12/7/2009; 451 words; DANBURY, Conn. -- Biodel Inc. (Nasdaq: BIOD) will issue its fourth quarter and fiscal...archived and available for replay through the website. About Biodel Inc. Biodel Inc. is a specialty biopharmaceutical company focused on the...
FORM 8-K: BIODEL ANNOUNCES ENTRY INTO MATERIAL DEFINITIVE AGREEMENT
US Fed News Service, Including US State News; 11/20/2009; 890 words; WASHINGTON, Nov. 18 -- BIODEL INC., Danbury, Conn., files Form...registrant as specified in its charter is BIODEL INC. State of Incorporation: Delaware...Definitive Agreement. On Nov. 12, Biodel Inc. (the "Company") and N.V...
Oscient Raises $60M Through Sale Of 3.5% Convertible Notes.
BIOWORLD Today; 11/3/2009; 801 words; ...oncology-related indications. o Carrington Laboratories Inc., of Irving, Texas, entered into definitive agreements...Thursday, or 10.2 percent, to close at $1.77. o Biodel Inc., of Danbury, Conn., set the terms for its proposed...
Biodel Makes Strong Debut On Nasdaq Following $75M IPO.
BIOWORLD Today; 11/3/2009; 1441 words; Staff Writer Shares of Biodel Inc. shot up 19 percent on...25 million, the total Biodel had hoped to raise when...shares, or 8.3 percent. Biodel had about 19.4 million...Morgan Stanley & Co. Inc. is acting as the sole...
Recent News Articles
- Biodel Inc. to Present at Oppenheimer 20th Annual Healthcare Conference on November 3rd, 2009.(Conference news)
Business Wire - October 30, 2009 - Biodel Inc. to Present at Morgan Stanley 2009 Global Healthcare Unplugged Conference on September 14th, 2009.(Conference news)
Telecommunications Weekly - September 30, 2009 - Biodel Inc. to Present at Morgan Stanley 2009 Global Healthcare Unplugged Conference on September 14th, 2009.(Conference news)
Business Wire - September 11, 2009 - Biodel Inc. - Therapeutic Competitors.
M2 Presswire - June 22, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning